A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM) - Concepedia

Concepedia

Publication | Open Access

A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM)

DOI Full Paper Access

10

Citations

12

References

2023

Year

Alimu Dayimu, Avinash Gupta, Rubeta Matin, Jenny Nobes, Ruth Board, Miranda Payne, Ankit Rao, Alberto Fusi, Sarah Danson, Bryony Eccles,

European Journal of Cancer

References

	Year	Citations

Page 1